-
1.
公开(公告)号:EP3501544A1
公开(公告)日:2019-06-26
申请号:EP17843478.3
申请日:2017-08-17
发明人: NISHIYAMA, Nobuhiro , TAKEMOTO, Hiroyasu , NOMOTO, Takahiro , TOMODA, Keishiro , MATSUI, Makoto , YAMADA, Naoki , HONDA, Yuto , ISHII, Hideshi , MORI, Masaki , KONNO, Masamitsu
IPC分类号: A61K47/42 , A61K45/00 , A61K47/32 , A61K47/34 , A61K47/66 , A61K49/00 , A61K49/14 , A61P35/00
摘要: The present invention pertains to a ligand that contains a plurality of groups represented by formula (1) and is capable of multivalently binding to a glutamine transporter expressed in excess in a cancer cell compared to a normal cell.
-
公开(公告)号:EP3400941A1
公开(公告)日:2018-11-14
申请号:EP17735999.9
申请日:2017-01-05
发明人: SAYA, Hideyuki , NAGANO, Osamu , TSUCHIHASHI, Kenji , SUINA, Kentaro , NISHIYAMA, Nobuhiro , TAKEMOTO, Hiroyasu , NOMOTO, Takahiro , MATSUI, Makoto , TOMODA, Keishiro , YAMADA, Naoki , NISHIMORI, Tsukasa
IPC分类号: A61K31/4402 , A61K9/08 , A61K31/655 , A61K31/77 , A61K47/34 , A61K47/50 , A61P35/00
CPC分类号: A61K9/08 , A61K31/4402 , A61K31/655 , A61K31/77 , A61K47/34 , A61K47/50
摘要: The present invention is directed to provide antitumor agent including water-soluble sulfasalazine as an active ingredient. Antitumor agents were obtained with, as the water-soluble sulfasalazine, a PEG-modified sulfasalazine represented by the following formula:
wherein an average value of n is 4 or larger and 1136 or smaller.
-